Showing results (151-160 of 425) with videos related to

Sort By:
Pageof 43
Blood|January 16, 2024
A randomized phase 2 trial of oral vitamin A for graft-versus-host disease in children and young adultsPooja Khandelwal, Lucille Langenberg, Nathan Luebbering, et al.
Cancer Research|November 3, 2004
Failed adoptive immunotherapy with tumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2Sameek Roychowdhury, Kenneth F May, Katherine S Tzou, et al.
Cell|January 11, 2024
Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell deathZhenlong Li, Rui Ma, Hejun Tang, et al.
Blood|July 23, 2005
Human CTLA4 knock-in mice unravel the quantitative link between tumor immunity and autoimmunity induced by anti-CTLA-4 antibodiesKenneth D Lute, Kenneth F May, Ping Lu, et al.
The Journal of Clinical Investigation|April 15, 2025
Off-the-shelf invariant NKT cells expressing anti-PSCA CAR and IL-15 promote pancreatic cancer regression in miceZhenyu Dai, Zheng Zhu, Zhiyao Li, et al.
Blood|March 2, 2012
miR-155 regulates IFN-γ production in natural killer cellsRossana Trotta, Li Chen, David Ciarlariello, et al.
Leukemia Research|August 8, 2009
A novel mouse model for the aggressive variant of NK cell and T cell large granular lymphocyte leukemiaAkihiko Yokohama, Anjali Mishra, Takeki Mitsui, et al.
Blood|March 16, 2004
Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cellsTakehito Igarashi, Jason Wynberg, Ramprasad Srinivasan, et al.
Cancer Discovery|July 26, 2019
The Mechanism of Anti-PD-L1 Antibody Efficacy against PD-L1-Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic EffectorWenjuan Dong, Xiaojin Wu, Shoubao Ma, et al.
Blood|November 10, 2009
CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsetsJianhua Yu, Hsiaoyin C Mao, Min Wei, et al.
Pageof 43